Health
globalreutersAugust 2, 20241 Mins read
Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors
globalreutersAugust 2, 20241 Mins read 
The FDA approved Adaptimmune Therapeutics’ Tecelra as a treatment for advanced cases of synovial sarcoma. It’s the first engineered cell therapy approved for treating a solid tumor.
The post Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors appeared first on MedCity News.
Recent Posts
Categories
Related Articles
Tatiana Fofanova demos Koda Health
Tatiana Fofanova is the CEO of Koda Health. She is dealing with...
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
Kura Oncology already had a broad development plan for ziftomenib in leukemias,...
Health economic value of postacute oral nutritional supplementation in older adult medical patients at risk for malnutrition
That is my recent paper with co-authors Shanshan Wang, Jason Shafrin, and...
How Much More Would People Pay in Premiums if the ACA’s Enhanced Subsidies Expired?
Enhanced Affordable Care Act (ACA) subsidies lower premium payments for ACA Marketplace...
Leave a comment